openPR Logo
Press release

2025 Non-Steroidal Anti-inflammatory Drugs Industry Trends Report: Long-Term Outlook Through 2034

06-30-2025 09:23 AM CET | Health & Medicine

Press release from: The Business Research Company

Non-Steroidal Anti-inflammatory Drugs

Non-Steroidal Anti-inflammatory Drugs

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

How Large Will the Non-Steroidal Anti-inflammatory Drugs Market Size By 2025?
In recent years, the non-steroidal anti-inflammatory drugs market has seen robust growth. The market, which was worth $20.68 billion in 2024, is predicted to increase to $22.1 billion in 2025, showing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the historical period include chronic inflammatory diseases, postoperative pain management, sports injuries, over-the-counter availability, an aging population, and increased consumer awareness.

How Big Is the Non-Steroidal Anti-inflammatory Drugs Market Size Expected to Grow by 2029?
The market size for non-steroidal anti-inflammatory drugs is projected to experience significant growth in the forthcoming years. The market is expected to expand to $28.79 billion by 2029, registering a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is largely driven by developments in pain management treatments, regulatory shifts, the adoption of telehealth, global health and wellness trends, competition from biosimilars, patient choices, and targeted medicine strategies. Key trends in this period include dominance of the over-the-counter (OTC) market, increased demand for cox-2 inhibitors, generics and market competition, and the incorporation of digital health technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Which Key Market Drivers Powering Non-Steroidal Anti-inflammatory Drugs Market Expansion and Growth?
The increase in cases of chronic pain is anticipated to foster the expansion of the non-steroidal anti-inflammatory drugs market in the future. Chronic pain is a discomfort enduring more than six months. Non-steroidal anti-inflammatory drugs serve the purpose of managing injuries and chronic pain. As an illustration, a report from the CDC (Centers for Disease Control and Prevention), a US-based government agency, revealed in April 2022 that arthritis, affecting millions of Americans, is a frequent source of chronic pain. About one in four adults with arthritis, equivalent to 15 million people, suffer from intense joint pain related to arthritis. Hence, the escalating prevalence of chronic pain is contributing to the growth of the non-steroidal anti-inflammatory drugs market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Non-Steroidal Anti-inflammatory Drugs Market?
In the market for non-steroidal anti-inflammatory drugs, a primary trend is product advancement. The dominant firms in this sector are focusing on inventing new technological solutions. For instance, Endo International plc, a pharmaceutical firm headquartered in Ireland, initiated the distribution of ibuprofen-famotidine 800 mg/26.6 mg tablets in March 2024. These tablets amalgamate the pain-relieving and anti-inflammatory features of ibuprofen along with the gastric-protective effects of famotidine. This mix is engineered to provide pain relief while also reducing the chance of digestive side effects which can arise from the long-term usage of NSAIDs such as ibuprofen.

What Are the Emerging Segments in the Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented -

1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp

Who Are the Global Leaders in the Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market are Pfizer Inc., Bayer AG, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., Assertio Therapeutics Inc., Iroko Pharmaceuticals Inc., Reckitt Benckiser Group PLC, Perrigo Company PLC, Hikma Pharmaceuticals Public Limited Company, Glenmark Pharmaceuticals Limited, Septodont, Aspen Pharmacare Holdings Limited, Sagent Pharmaceuticals Inc., Advanced Pharma Inc., Akorn Operating Company LLC, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Lupin Limited, Cipla Limited, Zydus Cadila Healthcare Limited, Aurobindo Pharma Limited, Sanofi S.A., GlaxoSmithKline PLC, Horizon Therapeutics PLC, Zyla Life sciences, Novartis AG, Roche Holding AG, AbbVie Inc., Bristol-Myers Squibb Company

Which are the Top Profitable Regional Markets for the Non-Steroidal Anti-inflammatory Drugs Industry?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8023

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2025 Non-Steroidal Anti-inflammatory Drugs Industry Trends Report: Long-Term Outlook Through 2034 here

News-ID: 4086413 • Views:

More Releases from The Business Research Company

Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up to 2030
Future Perspective: Key Trends Shaping the Signal Conditioning Modules Market Up …
The signal conditioning modules market is on track for significant expansion over the coming years, driven by advancements in various industrial and technological sectors. This growth reflects the increasing need for precise signal management and integration with emerging smart technologies that are shaping modern automation and data acquisition systems. Projected Growth Trajectory of the Signal Conditioning Modules Market The signal conditioning modules market is anticipated to reach a valuation of $1.77
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
Emerging Sub-Segments Transforming the Set-Top Box Market Dynamics
The set-top box market is on the cusp of significant expansion as technology and consumer preferences continue to evolve rapidly. With the increasing demand for advanced streaming and broadcasting solutions, this sector is poised for substantial growth over the coming years. Let's explore the market's projected size, leading companies, key trends, and the segments driving this development. Projected Market Growth of the Set-Top Box Industry by 2030 The set-top box market
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Wafer Market
Market Trend Analysis: The Impact of Recent Innovations on the Semiconductor Waf …
The semiconductor wafer sector is gearing up for significant expansion as technological advancements and diverse industry demands drive its growth. With applications spanning from electric vehicles to telecommunications, this market is positioned for steady development in the years ahead. Let's explore the anticipated market size, key players, emerging trends, and segmentation details shaping the future of this vital industry. Projected Market Size and Growth Trajectory of the Semiconductor Wafer Market Forecasts
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Equipment Market
Leading Companies Reinforce Their Presence in the Semiconductor Manufacturing Eq …
The semiconductor manufacturing equipment market is poised for significant expansion as the demand for high-performance chips and advanced packaging technologies continues to grow. This evolving sector is driven by technological progress and increased investments, setting the stage for substantial developments through 2030. Projected Semiconductor Manufacturing Equipment Market Size and Growth The semiconductor manufacturing equipment market is forecasted to reach a value of $196.07 billion by 2030, growing at a compound annual

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the